Physician profile
Stanislav Weiner
NPI 1003801705
$249,348.34
in general payments reported to CMS, 2019-2025
27 companies · $81K in 2025
The $81K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $16K · 2021: $9,474 · 2022: $18K · 2023: $42K · 2024: $61K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125K · Consulting Fee: $36K · Travel and Lodging: $13K · Food and Beverage: $9,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125,287.50 |
| Consulting Fee | $35,837.50 |
| Travel and Lodging | $12,553.85 |
| Food and Beverage | $9,494.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $205,409.46 | 2019-2025 | General - Ep, Rhythmia Mapping System, General - Therapies |
| Medtronic, INC. | $18,625.55 | 2021-2025 | Affera Mapping System, Micra, Na |
| Abbott Laboratories | $7,711.67 | 2021-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Medtronic Vascular, INC. | $6,359.68 | 2019-2020 | |
| Biosense Webster, INC. | $5,274.26 | 2019-2023 | Carto 3 |
| Atricure, INC. | $2,440.99 | 2022 | |
| Acutus Medical, INC. | $1,456.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.39 | 2019-2025 | Lifevest |
| Zoll Respicardia, INC. | $236.70 | 2023-2025 | Remede System |
| Altathera Pharmaceuticals LLC | $210.29 | 2023-2025 | Sotalol Hydrochloride |
| E.R. Squibb & Sons, L.L.C. | $194.53 | 2019-2024 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $191.45 | 2019-2024 | |
| Pfizer INC. | $164.52 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $162.36 | 2023-2024 | Optimizer, Optimizer |
| Ebr Systems, INC. | $153.03 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $119.27 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $66.78 | 2025 | Inspire |
| Preventice Services, LLC | $36.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $33.57 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $30.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.19 | 2019 | |
| Philips North America LLC | $22.61 | 2025 | Lm Accessories |
| Cardiva Medical, INC. | $19.18 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Lundbeck LLC | $16.84 | 2019 | |
| Medtronic USA, INC. | $16.36 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanislav Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.